placeSouth Africa
Contact us
Minimally Invasive Therapies / Clinical Solutions / Medtronic Lung Health

Lung Cancer is the most commonly diagnosed cancer and the leading cause of cancer mortality worldwide

84% of lung cancer cases are diagnosed at a late stage1

85% of Lung Cancer cases are caused by smoking

Average 5 year survival of Lung Cancer is 15%2

84% of lung cancer cases are diagnosed at a late stage

Lung cancer remain the leading cause of cancer death, with an estimated 1.8 million deaths (18%)3

Medtronic is committed to improve patient outcomes through innovative solutions 

Achieving Earlier Diagnosis

Together we can further optimize health outcomes through early diagnosis and early recovery, combing innovative technologues and comprehensive medical education programmes for all healtchcare providers involved in patient care.

Improving Survival Rates & Quality of Life

Together we can refine patients' journey through the care continuum enabling them to get deeper understanding and better preparation, which will eventually descrease physical pain and emotional distress for a faster return to normal life.

Optimizing Cost Efficiency

Together we can offer solutions that streamline the patient pathway and optimize the care continuum through enhancing partnerships that combine managed services, consultative expertise and innovative technology.

  • 1. American Lung Association 27.5.20 

  • 2. Drope J, Schluger N, Cahn Z, et al. The Tobacco Atlas. [Internet]. Atlanta: American Cancer Society and Vital Strategies; [cited 3 June 2019]. Available from: https://tobaccoatlas.org/

  • 3.https://acsjournals.onlinelibrary.wiley.com/doi/full/10.3322/caac.21660

CORPORATE RESOURCES
Minimally Invasive Therapies
Medtronic Africa

Waterfall Distribution Campus

Corner K101 & Bridal Veil Road

Waterfall, Midrand, Gauteng

1685

South Africa

©2024 Medtronic